FLI1 and non-small cell lung carcinoma: It was reported that SE-lncRNA smooth muscle and endothelial cell-enriched migration/differentiation-associated lncRNA (SENCR) were highly overexpressed in cisplatin-resistant A549/DDP cells, and it promoted cisplatin resistance and growth of NSCLC through upregulating FLI1 (Shen et al., 2022).